OSCR Quantitative Stock Analysis

Validea's guru fundamental report indicates Oscar Health Inc (OSCR) achieved a 60% rating using the Kenneth Fisher Price/Sales Investor model, which prioritizes low P/S ratios, long-term profit growth, strong free cash flow, and consistent profit margins. While OSCR passed the Price/Sales Ratio and Free Cash Per Share criteria, it failed on Long-Term EPS Growth Rate and Three-Year Average Net Profit Margin, placing it below the 80% threshold for 'some interest' and 90% for 'strong interest' within the strategy, suggesting underlying profitability challenges despite its valuation appeal.

Analysis

According to a Validea fundamental report, Oscar Health Inc. (OSCR) presents a mixed profile under the Kenneth Fisher Price/Sales Investor model, achieving a score of 60%. This rating is below the 80% threshold that typically indicates initial interest from the strategy. The company screens favorably on key value and cash flow metrics, passing tests for its Price/Sales Ratio and Free Cash Per Share. However, these positive attributes are significantly offset by weaknesses in core profitability and growth, as OSCR fails the criteria for both Long-Term EPS Growth Rate and Three-Year Average Net Profit Margin. This specific combination suggests that while the mid-cap growth stock may appear attractively valued relative to its sales and demonstrates an ability to generate cash, it has not yet established a track record of consistent, long-term profitability, a critical component of the Fisher strategy.

Key Decisions for Investors

• Investors attracted to the favorable Price/Sales ratio should scrutinize the underlying causes of the poor profitability metrics before considering a position.
• The failure on long-term EPS growth and average net profit margin criteria serves as a significant red flag, suggesting caution is warranted until there is clear evidence of a sustainable path to profitability.
• Given the 60% score falls short of the model's 80% interest threshold, investors might consider OSCR a 'hold' or place it on a watchlist, pending material improvement in its earnings and margin profiles.